P
Profusa
Medical devices company creating tissue-integrated sensors for chronic disease management and healthy living
About Profusa
Profusa is a biotechnology company specializing in the development of biosensors that provide continuous, real-time monitoring of tissue oxygen levels. The company serves healthcare providers and researchers by offering advanced microsensing technology that can detect early signs of diseases such as chronic limb-threatening ischemia and influenza. Operating in the medical technology market, Profusa's business model focuses on the commercialization of its Oxygen Platform and glucose biosensors. The company generates revenue through the sale of these devices and related software solutions. Profusa's technology is particularly valuable for critical care management and remote patient monitoring, making it a key player in the telehealth and medical diagnostics sectors.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2009
- Headquarters
- Berkeley, United States
- Employees
- 56
- Open positions
- None listed
- Dealroom signal
- 78.4/100
- Industry
- Health
- Sub-industry
- BioTechnology, Medical Devices
- Sector
- Biotech & Life Sciences, Biotechnology, Remote Monitoring, Tech for Patients, SPAC Target, SPAC IPO Announced, Hard Tech
- Technology
- Deep Tech, Recognition Technology
- Business model
- Manufacturing, SaaS
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| POST IPO DEBTDebt | Jul 2025 | $100M | — | Ascent Partners Fund | ↗ |
| SPAC IPOOther financing | Nov 2022 | $0 | — | NorthView Acquisition Corp | ↗ |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Profusa is 3K monthly website visits, up 7.1% over the last three months. Profusa's team grew 3.7% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A4 investors entered at this stage
Asset Management Ventures
3E Bioventures
Sand Hill Angels
Wealthing VC Club
Series B and later6 investors entered at this stage
VMS Group- VGVMS Investment Group
Tasly Pharmaceutical
Atinum Investment- NCNorthView Acquisition Corp
Ascent Partners Fund
Other known investors1 additional known investor
- MVMaxim Ventures
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Profusa on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Profusa’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.